![]() |
Hormone Replacement Therapy vs. Hormonal Treatment: What's the Difference?
|
![]() |
Hormonal Therapy for Prostate Cancer
|
![]() |
Hormonal Therapy for Breast Cancer: Assessing Benefits and Side Effects
|
![]() |
Hormonal Therapy for Breast Cancer: New Options
|
![]() |
Understanding Hormonal Therapy for Early Stage Breast Cancer
|
![]() |
Hormonal Therapy for Breast Cancer: Current Issues
|
Natural estriol, estradiol, estrone, and progesterone are available as:
Estradiols are available as skin patches (Estraderm, Vivelle, Climera) that slowly and continuously release estrogen through the skin into the bloodstream, bypassing the liver. The patches are worn at all times and changed once or twice per week.
Oil-based micronized oral progesterone appears to be most-readily utilized by the body, since the oil protects the progesterone from stomach acids. Some research suggests that a natural vitamin-E base (tocopherol) is more effective and least toxic. Mineral-oilbased preparations may not be effectively absorbed and/or metabolized.
Testosterone as DHEA is available as:
NHRT creams and gels are absorbed rapidly through the skin in areas with high blood flow, such as the lower neck, upper chest, inner wrists, or hands. Lower dosages are used for NHRT creams and gels because they are absorbed into the bloodstream more efficiently than oral NHRT. Transdermal preparations bypass the gastrointestinal tract and the liver where side effects are more likely to occur. With creams and gels, individual dosages can be adjusted easily, according to symptom relief. Low-dosage natural progesterone creams are available without a prescription. However, absorption of transdermals is highly variable between patients. Those with dry skin, poor circulation, etc. absorb less transdermally. Studies also show that transdermal delivery of hormones may result if very high blood levels over time. More research is need in this area, but for this reason some physicians do not prefer transdermal delivery forms.
Some NHRTs mix highly concentrated estrogen, progesterone, and sometimes testosterone in a propylene glycol base for rapid absorption through the skin. Only one to four drops are required daily, costing as little as $70 per year.
Typical NHRTs include:
Vaginal creams, tablets, and rings are not significantly absorbed into the bloodstream. However they can be useful for treating menopausal symptoms such as urinary problems, vaginal dryness, and thinning of the vaginal wall, which can cause painful intercourse. Vaginal NHRTs include:
Most effective NHRTs require a prescription and may be covered by insurance.
The dosages and duration of NHRT vary according to response, as determined by symptom relief. Dosages in women may be cycled to correspond to the menstrual cycle.
Symptoms of hormone imbalance in teenagers and young women with normal menstrual cycles include:
A typical NHRT is micronized progesterone cream, 4–6 mg per kg (2.2 lb) body weight, rubbed daily on the neck, upper chest, and inner wrists, for the entire month or for two weeks prior to menstruation, depending on symptoms. It is not used on the face in the presence of acne.
Symptoms of hormone imbalances in women in their twenties and thirties with normal menstrual cycles, in addition to the above, may include:
Typical NHRTs for three months to one year:
In addition to the above symptoms, hormone imbalances in premenopausal women (aged 35 to over 40), with regular or irregular menstruation, may cause:
Typical NHRTs for three months to one year:
NHRT may be particularly appropriate for perimenopausal symptoms in women aged 40–55. Their symptoms can be similar to those listed above, but may be more pronounced. Menstruation may have ceased or cycles may be irregular. Typical NHRTs:
Daily NHRT is continued for two to four months, followed by a five-day break.
Menopausal and postmenopausal women (usually aged 55 or older) may have, in addition to any of the above symptoms:
Typical NHRTs:
|
|
Author Info: Margaret Alic PhD, The Gale Group Inc., Gale, Detroit, Gale Encyclopedia of Alternative Medicine, 2005 |